INSTITUT PASTEUR;Centre National de la Recherche Scientifique;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE;Université de Nantes
发明人:
申请号：
EP13305086.4
公开号：
EP2759301A1
申请日:
2013.01.24
申请国别(地区):
EP
年份:
2014
代理人:
摘要：
The invention relates to a genetically modified infectious measles virus derived from a live-attenuated measles virus strain, in which the gene encoding the viral accessory C protein has been knocked out (MV-deltaC). It concerns in particular the use of said genetically modified infectious MV-deltaC in the treatment of malignant tumour or cancer conditions, and for the preparation of agents or compositions for such treatment.
